findmyKOL
Clinical trialNCT01835587CompletedPhase 1/PHASE2Interventional

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

SponsorCelgeneEnrollment31Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Queen Elizabeth Hospital Uhb Nhs Foundation Trust

    Birmingham, United Kingdom

United States
  • Memorial Sloan-Kettering Cancer Center.

    New York, New York, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

  • Md Anderson Cancer Center the University of Texas

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Oct 2013
Primary completion
13 Nov 2016
Completion
26 May 2017
Last update posted
20 Nov 2018
Registered enrollment
31
Registry id
NCT01835587

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.